GeekWire Studios: AWS re:Invent Spotlight | Accenture: Merck
December 20, 2024
59,177
106
0.18%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Geekwire Episodes Around December 20, 2024
See what was published immediately before and after this episode.
8:28Now PlayingGeekWire Studios: AWS re:Invent Spotlight | Accenture: Merck
YouTube Description
as posted by the channelGeekWire Studios: AWS re:Invent Spotlight | Accenture: Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Sean Finnerty
AVP, Cloud and Infrastructure Technology
Merck
Jeff Feist
Executive Director — Hosting Solutions
Merck
Steph Stricklen
Host
GeekWire Studios
Learn more at and
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.









